Monday, August 31, 2026

Seoul Asan Hospital Dominates Newsweek’s 2026 Asia-Pacific Rankings: 5 Clinical Areas at #1!

Seoul Asan Medical Center ranks first in five specialties in Newsweek's 2026 Asia-Pacific Best Hospitals, showcasing its medical excellence.

Future of Urban Air Mobility Shaped by Florida-Inha University Partnership!

On May 27, Incheon's Inha University announced...

Jensen Huang Says Chip Ban Cut NVIDIA’s China Market in Half

Jensen Huang critiques U.S. chip export controls, noting they harm NVIDIA's market share and boost China's chip development efforts.

Tag: Appclon

AbClon Secures Japanese Patent for Dual-Antibody Cancer Drug AM105: What This Means for Global Markets

AbClon has completed the registration of a Japanese patent for its next-generation dual antibody immuno-oncology candidate AM105.

Top News

- Our Sponsors Ad -

Follow us